Marmande

This research aims to evaluate the safety and performance of the SYMBOL range of medical devices used in total hip arthroplasty (THA) procedures. It focuses on patients undergoing either primary or revision total hip replacements due to various hip conditions, including degenerative hip joint disease, post-traumatic osteoarthritis, hip arthritis, femoral neck fractures, avascular necrosis of the femoral head, or failure of previous joint implants. The study will follow patients for a period of 10 years to assess long-term outcomes. Participants will receive total hip arthroplasty using at least one medical device from the SYMBOL range. The study monitors the survivorship of 13 individual SYMBOL orthopedic components over the 10 years following surgery. Both primary and revision hip replacement procedures are included, and the devices used are those manufactured by DEDIENNE Santé under the SYMBOL range. During the study, patients will be regularly assessed to monitor the performance and safety of the implanted devices. Researchers will track the longevity of the implants and watch for any complications or failures. Participants must be able to read, write, and understand French and will provide informed consent. The study excludes those unable to follow procedures or who have previously participated with a SYMBOL device. The total duration of participation is 10 years post-operation, allowing comprehensive long-term monitoring.